GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Humana Inc (NYSE:HUM) » Definitions » ROE %

Humana (Humana) ROE %

: -13.03% (As of Dec. 2023)
View and export this data going back to 1971. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Humana's annualized net income for the quarter that ended in Dec. 2023 was $-2,164 Mil. Humana's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $16,606 Mil. Therefore, Humana's annualized ROE % for the quarter that ended in Dec. 2023 was -13.03%.

The historical rank and industry rank for Humana's ROE % or its related term are showing as below:

HUM' s ROE % Range Over the Past 10 Years
Min: 5.84   Med: 17.36   Max: 26.14
Current: 15.19

During the past 13 years, Humana's highest ROE % was 26.14%. The lowest was 5.84%. And the median was 17.36%.

HUM's ROE % is ranked better than
70% of 20 companies
in the Healthcare Plans industry
Industry Median: 8.89 vs HUM: 15.19

Humana ROE % Historical Data

The historical data trend for Humana's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humana Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.39 26.14 19.68 17.88 15.77

Humana Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.38 31.08 22.96 19.70 -13.03

Competitive Comparison

For the Healthcare Plans subindustry, Humana's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humana ROE % Distribution

For the Healthcare Plans industry and Healthcare sector, Humana's ROE % distribution charts can be found below:

* The bar in red indicates where Humana's ROE % falls into.



Humana ROE % Calculation

Humana's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=2489/( (15311+16262)/ 2 )
=2489/15786.5
=15.77 %

Humana's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-2164/( (16949+16262)/ 2 )
=-2164/16605.5
=-13.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Humana  (NYSE:HUM) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-2164/16605.5
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-2164 / 105848)*(105848 / 51485)*(51485 / 16605.5)
=Net Margin %*Asset Turnover*Equity Multiplier
=-2.04 %*2.0559*3.1005
=ROA %*Equity Multiplier
=-4.19 %*3.1005
=-13.03 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-2164/16605.5
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / EBIT) * (EBIT / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-2164 / -2364) * (-2364 / -1780) * (-1780 / 105848) * (105848 / 51485) * (51485 / 16605.5)
= Tax Burden * Interest Burden * EBIT Margin % * Asset Turnover * Equity Multiplier
= 0.9154 * 1.3281 * -1.68 % * 2.0559 * 3.1005
=-13.03 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Humana ROE % Related Terms

Thank you for viewing the detailed overview of Humana's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Humana (Humana) Business Description

Traded in Other Exchanges
Address
500 West Main Street, Louisville, KY, USA, 40202
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Executives
Susan M Diamond officer: Segment President, Home Bus. 500 W MAIN ST., LOUISVILLE KY 40202
Sanjay K Shetty officer: President, CenterWell 500 W. MAIN STREET, LOUISVILLE KY 40202
George Ii Renaudin officer: President, Medicare & Medicaid 500 W. MAIN SREET, LOUISVILLE KY 40202
Jones David A Jr/ky director C/O HUMANA INC, 500 WEST MAIN STREET, LOUISVILLE KY 40202
Timothy S. Huval officer: Sr. Vice Pres & Chief HR Offic 500 W. MAIN STREET, LOUISVILLE KY 40202
Bruce D Broussard officer: President 500 W. MAIN STREET, C/O HUMANA LAW DEPT., LOUISVILLE KY 40202
Joseph C Ventura officer: Chief Legal Officer & Corp Sec 500 W MAIN STREET, LOUISVILLE KY 40202
William Kevin Fleming officer: President, Hlthcare Svc Sgmt 500 WEST MAIN STREET, LOUISVILLE KY 40202
Timothy Alan Wheatley officer: President, Retail Segment 500 WEST MAIN STREET, LOUISVILLE KY 40202
Samir Deshpande officer: Chief Risk Officer 500 W MAIN STREET, LOUISVILLE KY 40202
Brad D Smith director 1040 13TH AVE, HUNTINGTON WV 25701
John-paul W. Felter officer: SVP, Chief Accting Off & Cont. 500 W MAIN ST, LOUISVILLE KY 40202
Michael A. Koeberlein officer: SVP, Chief Accting Off & Cont. 500 W MAIN ST., LOUISVILLE KY 40202
David T Feinberg director 1299 OCEAN AVENUE, SUITE 1000, SANTA MONICA CA 90401
Agwunobi, M.d. Andrew C. officer: Seg. President, Home Solutions HUMANA INC., 500 W MAIN STREET, LOUISVILLE KY 40202

Humana (Humana) Headlines

From GuruFocus

Q4 2022 Humana Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2021 Humana Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Humana Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Humana Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Humana Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Humana Inc Investor Day Transcript

By GuruFocus Research 01-23-2024

Humana Inc at Jefferies Healthcare Conference Transcript

By GuruFocus Research 01-23-2024